Heres what men should know about the GLP-1 landscape today
Direct-to-Consumer Pricing Was Already Cheaper Before the government deal, both companies launched direct-pay programs: LillyDirect (Zepbound) ~$500$600/month NovoCare (Wegovy/Ozempic) ~$499$650/month Costco ~ $499/month for a 4-week supply Expected to drop toward $350 $245 as the new deal phases in These prices became possible for one reason: They cut out the middlemen
Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway
Eligible patients lost an average of 13.6% of their body weight (-31.3 pounds) in a 64week clinical trial evaluating 25 mg oral semaglutide compared to those on 2.4mg injectable semaglutide who lost an average of 14.9% (-33.6 pounds) in a 68week clinical trial
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
Regulatory Landscape for GLP-1 Analogues Regulation of GLP-1 analogues is under the jurisdiction of health regulatory agencies, which ensure their safety, efficacy, and quality before approval